Physician profile
Chike Ilorah
NPI 1619382355
$5,170.29
in general payments reported to CMS, 2019-2025
19 companies · $1,030 in 2025
The $1,030 reported for 2025 was more than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $255 · 2022: $2,867 · 2023: $258 · 2024: $760 · 2025: $1,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,048.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,354.07 | 2022 | |
| Stryker Corporation | $636.88 | 2021-2025 | Evolve, Target, Surpass Evolve |
| Imperative Care, INC | $554.44 | 2022-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter, Zoom Rdl Radial Access System, 103cm |
| Eisai INC. | $492.03 | 2023-2025 | |
| Philips North America LLC | $300.51 | 2022-2023 | |
| Abbvie INC. | $252.82 | 2025 | |
| Siemens Medical Solutions USA, INC. | $131.65 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $102.05 | 2021 | |
| Pfizer INC. | $61.39 | 2025 | |
| Medtronic, INC. | $49.03 | 2025 | Solitaire X |
| Inspiremd Ltd | $42.10 | 2025 | Cguard Prime Carotid Stent System |
| Lilly USA, LLC | $36.74 | 2025 | Kisunla |
| Route 92 Medical, INC. | $29.79 | 2025 | |
| Axsome Therapeutics, INC. | $29.64 | 2025 | Symbravo |
| Tanabe Pharma America, INC. | $23.46 | 2025 | Radicava |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $22.77 | 2025 | Vyepti |
| Argenx US, INC. | $19.49 | 2025 | Vyvgart Hytrulo |
| Amgen INC. | $19.34 | 2025 | Uplizna |
| Neurelis, INC. | $12.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chike Ilorah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.